北京盈科（厦门）律师事务所 关于 北京盈科（厦门）律师事务所 关于三达膜环境技术股份有限公司 2026 年第一次临时股东会的 三达膜环境技术股份有限公司 2026 年第一次临时股东会的 法律意见书 www.yingkelawyer.com 福建省厦门市思明区鹭江道 2 号厦门第一广场 25 楼（361001） 电话：0592-2936688 传真：0592-2525625 法律意见书 致：三达膜环境技术股份有限公司 北京盈科（厦门）律师事务所（以下简称"本所"）接受三达膜环境技术股份有 限公司（以下简称"公司"）的委托，依据《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司 股东会规则》（以下简称"《股东会规则》"）等法律、法规和其他规范性文件以 及《三达膜环境技术股份有限公司章程》（以下简称"《公司章程》"）的有关规 定，指派律师出席了公司的2026年第一次临时股东会（以下简称"本次股东会"）， 并就本次股东会相关事项出具本法律意见书。 为出具本法律意见书，本所律师审查了公司本次股东会的有关文件和材料。本 所及本所律师假定公司所提供的原始材料 ...

证券代码：688101 证券简称：三达膜 公告编号：2026-014 三达膜环境技术股份有限公司 2026年第一次临时股东会决议公告 （一） 股东会召开的时间：2026 年 3 月 20 日 （二） 股东会召开的地点：福建省厦门市集美区锦亭北路 66 号三达科技园办公 楼三层 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 91 | | --- | --- | | 普通股股东人数 | 91 | | 2、出席会议的股东所持有的表决权数量 | 226,760,789 | | 普通股股东所持有表决权数量 | 226,760,789 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比例（%） | 68.2990 | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 68.2990 | （四） 表决方式是否符合《公司法》及公司章程的规定，股东会主持情况等。 本次股东会由公司董事会召集，董事长 CHEN NI 女士主持，会议采用现场投 票和网络投票相结合的表决方式。本次股东会的召集和召开程序、出席会议人员 ...

证券代码：688101 证券简称：三达膜 三达膜环境技术股份有限公司 2026 年第一次临时股东会会议资料 2026 年 3 月 三达膜环境技术股份有限公司 2026 年第一次临时股东会会议资料 三达膜环境技术股份有限公司 2026 年第一次临时股东会资料目录 | 三达膜 | 2026 | 年第一次临时股东会会议须知. | 3 | | | --- | --- | --- | --- | --- | | 三达膜 | 2026 | 年第一次临时股东会会议议程 | | 5 | | 三达膜 | 2026 | 年第一次临时股东会议案 | 7 | | | 议案一：《关于为全资子公司提供担保的议案》 | | | | 7 | | 议案二：《关于梅河口募投项目实施方式变更的议案》 | | | | 11 | | 议案三：《关于 | | 2025 年回报股东特别分红方案的议案》 | | 17 | 2 三达膜环境技术股份有限公司 2026 年第一次临时股东会会议资料 三达膜环境技术股份有限公司 2026 年第一次临时股东会会议须知 为了维护全体股东的合法权益，确保股东会的正常秩序和议事效率，保证会 议的顺利进行，根据《中华人民共和国 ...

证券代码：688101 证券简称：三达膜 公告编号：2026-013 三达膜环境技术股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度的提示性 公告 清源（中国）有限公司保证向本公司提供的信息真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的 信息一致。 一、 信息披露义务人及其一致行动人的基本信息 1.身份类别 | | □控股股东/实际控制人及其一致行动人 | | --- | --- | | 投资者及其一致行动人 | 5%以上大股东及其一致行动人 ☑其他 | | 的身份 | □合并口径第一大股东及其一致行动人（仅适用于无 | | | 控股股东、实际控制人） | | | □其他______________（请注明） | | | | 2.信息披露义务人信息 本次权益变动后，清源中国持有的公司股份数量由 82,362,230 股减少至79,682,896股，占公司总股本比例由24.81%下降至24.00%。 | 投资者名 | 变动前股数 | 变动前 | 变动后股数 | 变动后比 | 权益变动 | 权益变动的 | 资金来源 （仅增持 | | - ...

Core Viewpoint - The company reported preliminary financial data for the year 2025, indicating a positive growth trend in revenue and net profit, with a focus on membrane technology applications and water investment operations. Financial Performance and Indicators - The company achieved operating revenue of 151,975.34 million RMB, representing a year-on-year increase of 9.27% [4] - The net profit attributable to the parent company was 37,761.65 million RMB, reflecting a year-on-year growth of 19.95% [4] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 36,316.93 million RMB, with a year-on-year increase of 29.65% [4] - Total assets at the end of the reporting period were 632,055.77 million RMB, an increase of 3.25% from the beginning of the period [4] - Equity attributable to the parent company was 442,745.79 million RMB, up 9.39% from the beginning of the period [4] - The net asset value per share attributable to the parent company was 13.34 RMB, an increase of 9.43% from the beginning of the period [4] Factors Influencing Performance - The company maintained steady growth in membrane technology applications and water investment operations, with significant improvements in the acceptance scale of industrial separation projects compared to the same period last year, which positively impacted overall gross profit levels and supported steady profit growth [4]

Group 1 - The core point of the article is that SanDa Membrane reported its 2025 performance, showing a total operating revenue of 1,519.75 million yuan, which represents a year-on-year increase of 9.27% [2] - The net profit attributable to the parent company for 2025 was 377.62 million yuan, reflecting a year-on-year growth of 19.95% [2]

Group 1 - Hehe Information achieved operating revenue of 1.81 billion yuan in 2025, a year-on-year increase of 25.83%, and net profit of 454 million yuan, a year-on-year increase of 13.39% [1] - Shengyi Technology announced that Guangxin Group and Chen Renxi have completed their share reduction plan, with Guangxin Group reducing its shares by 24.29 million, accounting for 1% of the total share capital [2] - Huaci Co., Ltd. received approval from the China Securities Regulatory Commission for its stock issuance to specific targets [3] Group 2 - New Nuo Wei plans to transfer 30.07% of its shares in Guoxin Huijin to Shiyao Holdings for 230 million yuan, with a valuation increase of 94.85% [4] - Tianli Lithium Energy has completed the scheduled maintenance of its lithium iron phosphate production line and resumed production [5] - Jinchuan Electric reported a net profit of 81.218 million yuan in 2025, a year-on-year decrease of 10.87% [6] Group 3 - Shenzhou Taiyue reported a net profit of 798 million yuan in 2025, a year-on-year decrease of 44.09% [7] - Jingwei Hengrun achieved a net profit of 99.5375 million yuan in 2025, reversing a loss from the previous year [8] - Keheng Technology signed a maximum pledge contract worth 450 million yuan to support its supply chain procurement [9] Group 4 - Zhongchu Media reported a net loss of 20.2858 million yuan in 2025, with operating revenue of 157 million yuan, a year-on-year decrease of 18.99% [10] - Tongde Chemical's subsidiary is involved in a lawsuit with a claim amount of approximately 49.1824 million yuan [12] - Jichuan Pharmaceutical signed an exclusive commercialization rights agreement for a new eczema treatment, with payments not exceeding 190 million yuan [13] Group 5 - Tianli Lithium Energy reported a net loss of 211 million yuan in 2025, with operating revenue of 408 million yuan, a year-on-year decrease of 20.20% [14] - Fortune Trend achieved a net profit of 315 million yuan in 2025, a year-on-year increase of 3.62% [15] - CITIC Securities received approval to publicly issue corporate bonds totaling no more than 80 billion yuan [16] Group 6 - Yongshan Lithium Industry reported a reduction of 23 million shares by Ningbo Jutai, decreasing its total shareholding from 13.24% to 4.52% [17] - Taifu Pump Industry achieved a net profit of 17.5631 million yuan in 2025, a year-on-year increase of 38.78% [18] - Longxun Co., Ltd. reported a net profit of 172 million yuan in 2025, a year-on-year increase of 19.05% [19] Group 7 - Duori Pharmaceutical's acquisition offer period has expired, and the company's stock will resume trading [20] - Tianhao Energy obtained a loan commitment letter for stock repurchase from a financial institution, with a loan amount not exceeding 90 million yuan [21] - Lijun Co., Ltd. reported a net profit of 57.545 million yuan in 2025, a year-on-year decrease of 52.09% [22] Group 8 - Zhongchumai reported a net profit of 212 million yuan in 2025, a year-on-year increase of 45.55% [23] - Kangxino reported a net profit of 27.8727 million yuan in 2025, reversing a loss from the previous year [24] - Baiao Saitu achieved a net profit of 173 million yuan in 2025, a year-on-year increase of 416.37% [25] Group 9 - Guangxun Technology's private placement application was approved by the Shenzhen Stock Exchange [26] - Sandam Membrane reported a net profit of 378 million yuan in 2025, a year-on-year increase of 19.95% [27] - Shangsheng Electronics reported a net profit of 184 million yuan in 2025, a year-on-year decrease of 21.71% [28] Group 10 - Xin'an Century reported a net profit of 79.2904 million yuan in 2025, reversing a loss from the previous year [29] - Zhenlei Technology achieved a net profit of 133 million yuan in 2025, a year-on-year increase of 582.01% [30] - Fuan Pharmaceutical's subsidiary received approval for a new drug application [32] Group 11 - Baotai reported a net loss of 336 million yuan in 2025, with operating revenue of 934 million yuan [33] - Aohua Endoscope reported a net profit of 11.4619 million yuan in 2025, a year-on-year decrease of 45.45% [34] - Maide Medical reported a net profit of 65.2599 million yuan in 2025, reversing a loss from the previous year [35] Group 12 - Chip Original Co. reported a net loss of 528 million yuan in 2025, with operating revenue of 3.152 billion yuan [36] - Zhongwei Semiconductor set a preliminary transfer price of 43.35 yuan per share for its inquiry [37] - Tieke Railway reported a net profit of 171 million yuan in 2025, a year-on-year decrease of 20.09% [38] Group 13 - Changjiang Electric announced a cash dividend distribution plan of 2.1 yuan per 10 shares for the 2025 fiscal year [39] - Kunheng Shunwei reported a net profit of 46.7676 million yuan in 2025, a year-on-year increase of 26.28% [40] - Ailis reported a net profit of 2.181 billion yuan in 2025, a year-on-year increase of 52.55% [41] Group 14 - Aerospace Software reported a net loss of 11.3126 million yuan in 2025, with operating revenue of 1.216 billion yuan [42] - Qizhong Technology reported a net profit of 266 million yuan in 2025, a year-on-year decrease of 15.16% [43] - Guotou Zhonglu plans to acquire 70% of Luochuan Lingxian Company for 74.8745 million yuan [44] Group 15 - Aokema plans to acquire 45% of its subsidiary for 253 million yuan [45] - ST Dali signed a procurement framework agreement worth 88.8794 million yuan with a leading new energy company [46] - Zhifei Biological received clinical trial approval for a new mRNA vaccine [47]

Core Insights - The company, SanDa Membrane (688101.SH), reported a revenue of 1.52 billion yuan for the fiscal year 2025, reflecting a year-on-year growth of 9.27% [1] - The net profit attributable to the parent company's shareholders reached 378 million yuan, marking a year-on-year increase of 19.95% [1] Business Performance - The company maintained steady growth in membrane technology applications and water investment operations during the reporting period [1] - The scale of industrial separation project acceptance significantly improved compared to the same period last year, effectively enhancing the overall gross profit level of the company [1] - This improvement in gross profit contributed to a steady increase in the company's profitability [1]

Core Viewpoint - SanDa Membrane (688101.SH) reported a solid performance for the fiscal year 2025, with significant growth in revenue and net profit, indicating a strong position in membrane technology applications and water investment operations [1] Financial Performance - The company achieved an operating revenue of 1.52 billion yuan, representing a year-on-year increase of 9.27% [1] - The net profit attributable to the parent company was 378 million yuan, reflecting a year-on-year growth of 19.95% [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 363 million yuan, which is a year-on-year increase of 29.65% [1] Business Growth - The company maintained steady growth in membrane technology applications and water investment operations during the reporting period [1] - The scale of industrial separation project acceptance significantly improved compared to the same period last year, effectively enhancing the overall gross profit level of the company [1] - This improvement in gross profit contributed to a steady increase in profitability [1]

Financial Performance - Total revenue for 2025 reached RMB 151,975.34 million, representing a year-on-year increase of 9.27%[3] - Net profit attributable to shareholders of the parent company was RMB 37,761.65 million, up 19.95% compared to the previous year[5] - Net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was RMB 36,316.93 million, reflecting a growth of 29.65%[5] - Basic earnings per share increased to RMB 1.14, a rise of 20.00% from RMB 0.95 in the previous year[3] Assets and Equity - Total assets at the end of the reporting period were RMB 632,055.77 million, an increase of 3.25% from the beginning of the period[5] - Shareholders' equity attributable to the parent company rose to RMB 442,745.79 million, marking a 9.39% increase[5] - Net asset value per share attributable to shareholders of the parent company was RMB 13.34, up 9.43% from RMB 12.19[4] Operational Highlights - The company maintained steady growth in membrane technology applications and water investment operations, significantly improving overall gross profit levels[5] Financial Data Integrity - No financial data or indicators showed a change of 30% or more during the reporting period[7] - The financial data presented are preliminary and unaudited, with final figures to be confirmed in the 2025 annual report[8]